Please login to the form below

Not currently logged in
Email:
Password:

GLI names VP of scientific and regulatory affairs

Dr Brian Harvey joins from Pfizer

The Global Liver Institute (GLI) has name Dr Brian Harvey as executive vice president of scientific and regulatory affairs, having been a member since its founding in 2014.

In the role, Harvey will support and guide GLI on scientific, medical and regulatory matters, supporting the institute's aim to promote innovation, encourage collaboration between diverse partners and optimise approaches to beat liver diseases.

Founder and president of GLI, Donna Cryer, said: “Brian not only has a wealth of medical knowledge and experience as a practicing physician, but, having worked within both U.S. Food and Drug Administration and at several leading pharmaceutical companies, he brings to GLI extensive industry experience that will help us identify opportunities to transform the field of liver disease.”

Harvey joins from Pfizer, where he most recently served as VP of US regulatory strategy, covering pharma and biologics across all therapy areas. Prior to joining Pfizr, he held the role of VP of US regulatory policy for Sanofi-Aventis.

Harvey has also previously held positions at the FDA, including working as director of the regulator's division of gastroenterology products.

Commenting on his appointment, Harvey said: “I'm proud to join Donna and her team as they apply their new formula for advocacy and collaboration to tackle the complex public health issues surrounding liver disease.

“Liver disease affects over 30 million people in this country alone, and I believe GLI's approach to advocacy can not only raise awareness of liver disease, but rapidly develop and disseminate solutions that can improve the lives of patients and their families.”

22nd June 2015

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics